FRIDAY, Dec. 1, 2023 (Healthday News) -- In testimony provided Thursday to members of Congress, the head of the U.S. Centers for Disease Control and Prevention said that a surge in respiratory illnesses in China is not being fueled by a new virus.
Instead, the spike can be linked to existing viruses and bacteria, including COVID-19, the flu, respiratory syncytial virus (RSV) and Mycop...
THURSDAY, Nov. 16, 2023 -- To address a continuing nationwide shortage, more than 77,000 doses of RSV shots for infants were released Thursday by the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration.
The additional doses are of Beyfortus, a long-acting monoclonal antibody designed to protect infants too young for vaccination against RSV.
Measles deaths are surging worldwide, prompted by a wave of infections among unvaccinated children, public health experts say.
Deaths from measles increased by 43% globally in 2022 compared to the year before, resulting from an 18% increase in measles cases, the World Health Organization and the U.S. Centers for Disease Control and Prevention say in a new report published Thursday.
FRIDAY, Nov. 10, 2023 (Healthday News) -- In a sign that suggests many American parents have become dubious about the safety of childhood vaccines, new government data shows that immunization exemptions for kindergartners have reached their highest levels ever.
The latest statistics continue a decline in routine vaccinations for kids that increases the risk for highly contagious diseases,...
THURSDAY, Oct. 26, 2023 (HealthDay News) -- High-risk men should still get their mpox vaccinations even after the ongoing outbreak ends, advisors to the U.S. Centers for Disease Control and Prevention recommended Wednesday.
That vulnerable group includes men who have sex with men; people who have more than one sexual partner; those who have recently had a sexually transmitted disease; a...
Robin Foster and Ernie Mundell and Cara Murez HealthDay Reporters
Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19.
In interim findings from a Phase 1/2 trial, the vaccine showed both a strong immune response compared to the standard dose of flu vaccine in adults aged 50 to 64 and an enhanced flu shot in people aged 65 to 79. It also showed a strong res...
More than 80% of eligible Americans did not get a COVID-19 booster shot last fall. Now, a new study reveals the reasons for the hesitation.
Nearly 40% of survey participants said a prior COVID-19 infection factored into their decision to not get the booster. Another 31.5% were worried about side effects. And an additional 28% didn't think a booster would provide extra protection, while 23...
Despite reports of trouble last week where some people may have been denied insurance coverage while seeking COVID shots at pharmacies, the Biden administration said Thursday those issues have been ironed out.
That issue is "largely, if not completely," resolved after U.S. Health and Human Services Secretary Secretary
When pregnant women get a COVID vaccine, it helps protect their newborns from the virus, a new government study shows.
"These findings indicate that maternal vaccination during pregnancy could help prevent COVID-19--related hospitalization in infants too young to be vaccinated," researchers from the U.S. Centers for Disease Control and Prevention wrote.
Just 23% of American adults say they 'definitely' will get the new COVID-19 vaccine, while another 23% say they will 'probably' get it, according to a new poll, which also finds interest in the shot falls along partisan lines.
More people plan to get seasonal flu shots and the new vaccine to help prevent severe symptoms for respiratory syncytial virus or RSV.
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV).
Following approval one month ago by the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention on Friday also approved the shot, called Abrysvo. That marks the last hurdle needed for the vaccine to become widely available.
An oral vaccine for COVID-19 appears to produce the sort of immune response that could quickly stamp out a developing infection, according to results from a small-scale primate study.
Some monkeys given an experimental COVID vaccine tablet under their tongue developed the type of antibodies that might block the coronavirus as it attempts to infect the body through the mucous membranes of ...
Following on an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the U.S. Centers for Disease Control and Prevention on Tuesday also signed off on new COVID boosters for Americans.
Final approval is expected from CDC Director Dr. Mandy Cohen, which would set the stage for the updated vaccines to soon become available.
The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the updated vaccines to become available within days.
The COVID-19 shots from Pfizer and Moderna will join the flu shot and newly approved RSV shots as part of a three-pronged public health strategy to tame the spread of all three viruses this coming winter. The ...
In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South American winter, health officials report.
Even better, the flu virus strains that have been detected in the United States have so far shown a similar pattern to those in South America, although that could still change....
Some good news for folks who are worried about the new, troublesome COVID variant known as BA.2.86: Moderna Inc. said Wednesday that its updated vaccine held its own against this highly mutated version of the virus.
While approval for the newest version of the vaccine is still pending from the U.S. Food and Drug Administration, the company offered good reason for why the agency should gi...
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday
The vaccine is designed to be given to pregnant women between 32 and 36 weeks of pregnancy as a way to protect infants from birth through 6 months from the sometimes ...
Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals.
Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and diphtheria shot, with or without an added pertussis vaccine, are associated with a 25% to 30% reduced risk of Alzheimer's disease, according to researchers from t...
People may assume that a COVID-19 infection protects them the next time they encounter the virus, but that's not necessarily true.
A new study of 750 vaccinated seniors living in retirement homes and long-term care facilities found that those infected during the first omicron wave were actually more vulnerable to reinfection with a later wave.